Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company codeTEM
Company nameTempus AI Inc
IPO dateJun 14, 2024
Founded at2015
CEOMr. Eric P. Lefkofsky
Number of employees2400
Security typeOrdinary Share
Fiscal year-endJun 14
Address600 West Chicago Avenue
CityCHICAGO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code60654
Phone18009765448
Websitehttps://www.tempus.com/
Company codeTEM
IPO dateJun 14, 2024
Founded at2015
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data